arrow
J

Jia Wu

md anderson cancer center
H指数:42
被引数:6,001

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Using Induction Chemoimmunotherapy as a Bridge to Definitive Local Therapy for Non-Metastatic NSCLC: Real-World Outcomes From a Comprehensive Cancer Center

使用诱导化免疗法作为非转移性NSCLC患者接受根治性局部治疗的桥梁:来自综合癌症中心的真实世界结果

2026-09-010
PRE
Development of PET/CT-clinical nomograms for predicting lymph node metastasis in primary lung cancer

开发PET/CT-临床列线图以预测原发性肺癌淋巴结转移

2025-12-170
OAAI
MET Overexpression Is Associated with Superior Immunotherapy Benefit in Advanced Non-Small Cell Lung Cancer

MET过表达与晚期非小细胞肺癌中更优的免疫治疗效果相关联

2025-11-270
OAAI
Radiomics for Dynamic Lung Cancer Risk Prediction in USPSTF-Ineligible Patients

基于放射组学的动态肺癌风险预测(针对USPSTF非适用人群)

2025-10-230
OAAI
The evolving landscape of leptomeningeal metastases from NSCLC: an international, contemporary, multicenter cohort study

小脑膜转移瘤在非小细胞肺癌中的演变格局:一项国际、当代、多中心队列研究

2025-10-200
OAAI
CoCo-ST detects global and local biological structures in spatial transcriptomics datasets

Coco-st检测空间转录组数据集中的全局和局部生物结构

2025-10-130
OA
Poziotinib for EGFR exon 20-insertion NSCLC: Clinical efficacy of the phase 2 ZENITH trial and differential impact of EGFR exon 20 insertion location on sensitivity

poziotinib 用于 EGFR 外显子 20 插入型 NSCLC:ZENITH II 期试验的临床疗效及 EGFR 外显子 20 插入位点对敏感性的差异化影响

2025-09-240
OAAI
Machine-learning driven strategies for adapting immunotherapy in metastatic NSCLC

机器学习驱动的转移性非小细胞肺癌免疫治疗适应性策略

2025-07-240
OAAI
Machine Learning Prediction of Financial Toxicity in Patients with Resected Lung Cancer

基于机器学习的肺癌切除术后患者经济毒性预测

2025-07-160
PRE
Spatial and multiomics analysis of human and mouse lung adenocarcinoma precursors reveals TIM-3 as a putative target for precancer interception

人类和小鼠肺腺癌前体物的空间与多组学分析揭示TIM-3可作为癌症拦截的潜在靶点

2025-05-080
OA
Lung Cancer Risk Prediction in Patients with Persistent Pulmonary Nodules Using the Brock Model and Sybil Model

利用Brock模型和Sybil模型对持续性肺结节患者进行肺癌风险评估

CANCERS
IF4.4
2025-04-290
OA